2022
DOI: 10.37766/inplasy2022.12.0042
|View full text |Cite
|
Sign up to set email alerts
|

Contrast-enhanced ultrasound in the differentiation between the most common benign parotid gland tumors: a systematic review and meta-analysis

Abstract: Review question / Objective: To determine the utility of CEUS in the preoperative differentiation between pleomorphic adenomas (PAs) and Warthin’s tumors (WTs) of the parotid gland. Condition being studied: Recently, contrast-enhanced ultrasound (CEUS) has become a promising tool in distinguishing benign from malignant parotid gland tumors. However, its usefulness in differentiating various benign parotid tumors has not been determined so far. The preoperative differentiation of the most common parotid gland t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…The review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [18]. The study protocol was registered with the International Platform of Registered Systematic Review and Metaanalysis Protocols (INPLASY) under the number INPLASY202330068 [19].…”
Section: Study Guidancementioning
confidence: 99%
“…The review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [18]. The study protocol was registered with the International Platform of Registered Systematic Review and Metaanalysis Protocols (INPLASY) under the number INPLASY202330068 [19].…”
Section: Study Guidancementioning
confidence: 99%
“…The review was conducted according to the PRISMA 2020 (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines [24]. The study protocol was registered with the International Platform of Registered Systematic Review and Metaanalysis Protocols (INPLASY) under the number INPLASY2022120042 [25].…”
Section: Study Guidancementioning
confidence: 99%